TNFSF10 and neoplasm: Another study also used TRAIL to enhance the targeted antitumor activity of nanocarriers by conjugating TRAIL onto their surfaces.26 Our biodistribution analysis showed that zA4 showed improved tumor targeting and reduced liver enrichment in a THP-1 subcutaneous tumor-bearing model (Fig. 4a, b).